Active resources used by Theranostics at UHN
Scroll down to learn more about our selection of resources
QIPCM is a centralized collaboration platform offering the informatics infrastructure needed by researchers to share data among internal and external teams in a secure and regulatory compliant fashion.
Our program provides end-to-end testing and analysis support for clinical trials to improve consistency and reliability in clinical trial data.
Our infrastructure was designed to help clinical investigators achieve systematic image collection and improved collaboration. Our modular design equips us with the capacity to handle large volume functional and dynamic imaging data
The UHNRC provides radiopharmaceuticals for the investigational and commercial use from a facility operating in accordance with GMP regulations (Drug Establishment Licence).
Radiopharmaceuticals are part of an advanced imaging technology that uses medical isotopes to assess and treat patients at a cellular level. Using imaging radiopharmaceuticals, physicians can detect diseases earlier and more accurately monitor the effectiveness of treatments. Targeted therapeutic radiopharmaceuticals can be used to provide personalized treatment of cancers.
STTARR (Spatio-Temporal Targeting and Amplification of Radiation Response) Innovation Centre offers a suite of integrated, advanced imaging instruments and experimental capabilities, including CT, MR, PET, SPECT, Ultrasound, Photoacoustic Imaging, Optical Imaging, and Image-Guided Radiation Therapy.
The STTARR Innovation Centre brings together products, services, and technologies to accelerate cutting-edge and multidisciplinary translational research in oncology, cardiology, metabolic diseases, organ transplantation, and many other fields.
Our staff provides full support to academic and industry clients from study conception to completion. Services include study design, implementation, budgeting , histopathology services, advanced data analysis, and federal and provincial regulatory compliance.
UHN Research & Innovation Cores provide access to state-of-the-art facilities, equipment and expertise that enable high-quality research.
The UHN Research & Innovation Cores are integrated shared research resources that enable scientists to access instruments, technologies and services for their research studies. Managed by knowledgeable staff, these state-of-the-art services serve as catalysts to accelerate studies from the lab to patient care. These Services serve UHN research study teams and they are also available to investigators worldwide.
Cancer Clinical Research Unit (CCRU)
The CCRU is one of the largest clinical research centres dedicated to improving the treatment of cancer. The CCRU provides leadership, oversight and infrastructure for researchers within the Princess Margaret Cancer Centre. Every year Princess Margaret initiates upwards of 150 new clinical trials – at any one time we have close to 350 trials underway.
The CCRU is the central point of contact for any questions about the conduct of clinical research at Princess Margaret. Our team of dedicated internationally recognized experts helps guide investigators and study teams to achieve the highest quality research.
Ozmosis Research is a social enterprise, or not for profit, Clinical Trials Management Company and was founded in 2005. We are an experienced Clinical Trials Management Company offering a full spectrum of services.
Ozmosis@UHN was created to manage UHN’s relationship with Ozmosis, and to serve as an internal UHN conduit through which UHN investigators access Ozmosis’ and other services in a streamlined manner. We have a dedicated in house team to manage CTAs and ensure trials meet Health Canada requirements. This allows UHN investigators access to academic CRO expertise.
Ozmosis’ services can be customized to the specific requirements of each investigator. We incorporate drug development and clinical trials management expertise, quality service, and open communication throughout the clinical trial process.
Enabling and leading commercialization and industry partnership for a healthier world, we are the research commercialization hub located at Toronto’s University Health Network (UHN).
As the leading research commercialization institution in Canada, we are UHN’s catalyst for accelerating the world-class research and innovation at UHN into medical products, devices and therapies that improve care for patients around the world.
Technologies discovered and developed at UHN have already formed the basis for many global products and services including pharmaceuticals, biologics, devices, and diagnostics and represent the foundation for UHN spin-out companies such as Adela Bio Inc., Treadwell Therapeutics and AvroBio, amongst others.
The basic research initiatives and translational expertise of UHN’s research and clinical investigators continue to generate a large and growing portfolio of opportunities for corporate partnerships and alliances, and our seasoned team of business professionals shepherds the world-class science and discovery living at UHN toward maximum patient impact: medical products, devices and therapies that change lives globally.
The Joint Department of Medical Imaging (JDMI) Research Office proudly oversees the operations of and facilitates access to medical imaging infrastructure and personnel for the purposes of research and discovery. Centrally based out of the University Health Network we are one of Canada’s largest academic medical imaging departments. Key infrastructure that is available to support Theranostics includes:
- PET/CT, integrated clinical scanners at Princess Margaret Cancer Centre and Toronto Western Hospital combining fast, high-resolution and high-sensitivity PET with the functionalities of standalone X-ray CT imaging.
- PET/MR, an integrated whole-body PET and high field 3T MRI system dedicated for research activities.
- SPECT/CT, seven clinical scanners across Princess Margaret Cancer Centre, Toronto General Hospital and Toronto Western Hospital at UHN offer integrated SPECT and X-ray CT capabilities.
- Dedicated research imaging technologists and physicists to support protocol development, study design, and image post-processing activities.